# Biogen Completes Acquisition of RayThera Inc.

> ma · REPORTED · 2026-08-20

Biogen announced the completion of its acquisition of RayThera Inc., expanding its neuroscience and biologics portfolio. This transaction was confirmed in late August 2026 as part of Biogen's continued M&A activity in the neurology space.

About Biogen: Biogen is a global biotechnology company pioneering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease, serving patients worldwide.

- Company: Biogen
- Sector: biotech
- Primary source: https://www.biospace.com/latest-news-press-releases

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.